The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Feng, Jing ^a,b   Wang, Qing Shan ^a,b   Chiang, Ambrose ^c   Chen, Bao Yuan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; CIGARETTE SMOKE; FIBRINOGEN; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; COAGULATING AGENT; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; EMPHYSEMA; EXPOSURE; HEPATITIS; HYPOXIA; MALE; NONHUMAN; PROTEIN SYNTHESIS; RAT; SLEEP; WAKEFULNESS; ANIMAL; ANIMAL HEPATITIS; ANOXIA; BLOOD; ELECTROENCEPHALOGRAPHY; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; WISTAR RAT;

RATTUS;

ANIMALS; ANOXIA; BASE SEQUENCE; COAGULANTS; DNA PRIMERS; ELECTROENCEPHALOGRAPHY; EMPHYSEMA; HEPATITIS, ANIMAL; INTERLEUKIN-6; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; SLEEP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78049283901     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013201     Document Type: Article

References (55)

1. Barnes PJ (2010) Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med 7: e1000220.
2. Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L (2001) Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 68: 4-19.
3. Papaioannou AI, Mazioti A, Kiropoulos T, Tsilioni I, Koutsokera A, et al. (2010) Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respir Med 104: 275-282.
4. American Academy of Sleep Medicine (2005) The international classification of sleep disorders: diagnostic and coding manual; 2nd ed. WestchesterIL, pp 165-167.
5. Casey KR, Cantillo KO, Brown LK (2007) Sleep-related hypoventilation/ hypoxemic syndromes. Chest 131: 1936-1948.
6. Kardos P, Keenan J (2006) Tackling COPD: a multicomponent disease driven by inflammation. MedGenMed 8: 54.
7. Krachman SL, Chatila W, Martin UJ, Nugent T, Crocetti J, et al. (2005) Effects of lung volume reduction surgery on sleep quality and nocturnal gas exchange in patients with severe emphysema. Chest 128: 3221-3228.
8. Brijker F, van den Elshout FJ, Heijdra YF, Folgering HT (2001) Underestimation of nocturnal hypoxemia due to monitoring conditions in patients with COPD. Chest 119: 1820-1826.
9. O'Donoghue FJ, Catcheside PG, Eckert DJ, McEvoy RD (2004) Changes in respiration in NREM sleep in hypercapnic chronic obstructive pulmonary disease. J Physiol 559: 663-673.
10. Orem JM, Lovering AT, Vidruk EH (2005) Excitation of medullary respiratory neurons in REM sleep. Sleep 28: 801-807.
11. Chaouat A, Naeije R, Weitzenblum E (2008) Pulmonary hypertension in COPD. Eur Respir J 32: 1371-1385.
12. Sergi M, Rizzi M, Andreoli A, Pecis M, Bruschi C, et al. (2002) Are COPD patients with nocturnal REM sleep-related desaturations more prone to developing chronic respiratory failure requiring long-term oxygen therapy? Respiration 69: 117-122.
13. 2 greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest 101: 649-655.
14. Nunes DM, Mota RM, de Pontes Neto OL, Pereira ED, de Bruin VM, et al. (2009) Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung 187: 159-163.
15. Lewis CA, Fergusson W, Eaton T, Zeng I, Kolbe J (2009) Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax 64: 133-138.
16. Mueller Pde T, Gomes MD, Viegas CA, Neder JA (2008) Systemic effects of nocturnal hypoxemia in patients with chronic obstructive pulmonary disease without obstructive sleep apnea syndrome. J Bras Pneumol 34: 567-574.
17. Undas A, Kaczmarek P, Sladek K, Stepien E, Skucha W, et al. (2009) Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment. Thromb Haemost 102: 1176-1182.
18. Sabit R, Thomas P, Shale DJ, Collins P, Linnane SJ (2010) The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD. Chest 138: 47-51.
19. Olds RJ, Lane DA, Mille B, Chowdhury V, Thein SL (1994) Antithrombin: the principal inhibitor of thrombin. Semin Thromb Hemost 20: 353-372.
20. Doolittle RF (1984) Fibrinogen and fibrin. Annu Rev Biochem 53: 195-229.
21. Sadler JE (1998) Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 67: 395-424.
22. Gonzalez NC, Wood JG (2010) Alveolar hypoxia-induced systemic inflammation: what low PO(2) does and does not do. Adv Exp Med Biol 662: 27-32.
23. Chao J, Wood JG, Gonzalez NC (2009) Alveolar hypoxia, alveolar macrophages, and systemic inflammation. Respir Res 10: 54.
24. Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M (2009) Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 35: 1397-1405.
25. Lee JH, Lee DS, Kim EK, Choe KH, Oh YM, et al. (2005) Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med 172: 987-993.
26. Horner RL, Sanford LD, Annis D, Pack AI, Morrison AR (1997) Serotonin at the laterodorsal tegmental nucleus suppresses rapid-eye-movement sleep in freely behaving rats. J Neurosci 17: 7541-7552.
27. Feng J, Chen BY, Cui LY, Wang BL, Liu CX, et al. (2009) Inflammation status of rabbit carotid artery model endothelium during intermittent hypoxia exposure and its relationship with leptin. Sleep Breath 13: 277-283.
28. Feng J, Chen BY, Guo MN, Cao J, Zhao HY, et al. (2007) Changes of nuclear factor-kappaB and intercellular adhesion molecule-1 in endothelial cells exposed to various intermittent hypoxia. Zhonghua Jie He He Hu Xi Za Zhi 30: 202-206.
29. Feng J, Chen BY, Guo MN, Cao J, Zhao HY, et al. (2007) Interleukin-6 and tumor necrosis factor-alpha levels of endothelial cells in different hypoxia modes: in vitro experiment. Zhonghua Yi Xue Za Zhi 87: 774-777.
30. Wagner U, Staats P, Fehmann HC, Fischer A, Welte T, et al. (2006) Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD). J Occup Med Toxicol 1: 12.
31. Thurlbeck WM (1967) Internal surface area and other measurements in emphysema. Thorax 22: 483-496.
32. Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, et al. (1978) The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 298: 1277-1281.
33. Birrell MA, Wong S, Hele DJ, McCluskie K, Hardaker E, et al. (2005) teroidresistant inflammation in a rat model of chronic obstructive pulmonary disease is associated with a lack of nuclear factor-kappaB pathway activation. Am J Respir Crit Care Med 172: 74-84.
34. Barnes PJ, Celli BR (2009) Systemic manifestations and comorbidities of COPD. Eur Respir J 33: 1165-1185.
35. Mannino DM, Thorn D, Swensen A, Holguin F (2008) Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 32: 962-969.
36. Fabbri LM, Rabe KF (2007) From COPD to chronic systemic inflammatory syndrome? Lancet 370: 797-799.
37. van Eeden SF, Sin DD (2008) Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 75: 224-238.
38. Vaidyula VR, Criner GJ, Grabianowski C, Rao AK (2009) Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease. Thromb Res 124: 259-261.
39. Tapson VF (2005) The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2: 71-77.
40. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, et al. (2006) Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 16: 63-70.
41. Goldhaber SZ, Tapson VF; DVT FREE Steering Committee (2004) A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 93: 259-262.
42. Tillie-Leblond I, Marquette CH, Perez T, Scherpereel A, Zanetti C, et al. (2006) Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med 144: 390-396.
43. Ten VS, Pinsky DJ (2002) Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care 8: 242-250.
44. Gertler JP, Weibe DA, Ocasio VH, Abbott WM (1991) Hypoxia induces procoagulant activity in cultured human venous endothelium. J Vasc Surg 13: 428-433.
45. Gertler JP, Perry L, L'Italien G, Chung-Welch N, Cambria RP, et al. (1993) Ambient oxygen tension modulates endothelial fibrinolysis. J Vasc Surg 18: 939-946.
46. Rota S, McWilliam NA, Baglin TP, Byrne CD (1998) Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation: modulation by oxidation and vitamin E. Blood 91: 508-515.
47. Bendz B, Rostrup M, Sevre K, Andersen TO, Sandset PM (2000) Association between acute hypobaric hypoxia and activation of coagulation in human beings. Lancet 356: 1657-1658.
48. Becker HF, Piper AJ, Flynn WE, McNamara SG, Grunstein RR, et al. (1999) Breathing during sleep in patients with nocturnal desaturation. Am J Respir Crit Care Med 159: 112-118.
49. Fletcher EC, Miller J, Divine GW, Fletcher JG, Miller T (1987) Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tensions above 60 mm Hg. Chest 92: 604-608.
50. Krachman S, Minai OA, Scharf SM (2008) Sleep abnormalities and treatment in emphysema. Proc Am Thorac Soc 5: 536-542.
51. Koo KW, Sax DS, Snider GL (1975) Arterial blood gases and pH during sleep in chronic obstructive pulmonary disease. Am J Med 58: 663-670.
52. O'Reilly P, Bailey W (2007) Long-term continuous oxygen treatment in chronic obstructive pulmonary disease: proper use, benefits and unresolved issues. Curr Opin Pulm Med 13: 120-124.
53. American Thoracic Society (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152: S77-S121.
54. Plywaczewski R, Sliwinski P, Nowinski A, Kaminski D, Zielin ́ ski J (2000) Incidence of nocturnal desaturation while breathing oxygen in COPD patients undergoing long-term oxygen therapy. Chest 117: 679-683.
55. Kim V, Benditt JO, Wise RA, Sharafkhaneh A (2008) Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5: 513-518.